510(k) Report

510(k) · Decided

Decided

GlidePath 10F Long-Term Dialysis Catheter

K200627510(k) TraditionalDecided Jun 22, 2020104-day reviewClass II21 CFR 876.5540

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

C.R. Bard, Inc. · MSD Catheter, Hemodialysis, Implanted

Cleared on Jun 22, 2020 as substantially equivalent to K190527 (C. R. Bard, 2020) and 1 other predicate after a 104-day review. Its family tree reaches back 7 generations to 1998. 1 of the 15 devices in its family, counting itself, has a Class I recall. 2 later devices descend from it.

Decided
Jun 22, 2020
Review
104 days
Class
Class II
Product code
MSD
Recalls
None
Predicates
2

Its longest line of descent runs back 7 generations to K981994 (1998). 12 ancestors in all, the oldest K972207 (1998). 2 later devices descend from it, 1 citing it directly. 1 of the 15 devices in this family, counting this one, has a Class I recall.

  1. Root · 7 generations backK981994 Vascath Opti-Flow Long Term Dual Lumen Hemodialysis CatheterC.R. Bard, Inc. · 1998
  2. 6 generations backK012562 Medcomp 14.5F Double Lumen Hemodialysis CatheterMedical Components, Inc. · 2002
  3. 5 generations backK020465 Medcomp Ash Split-Cath IIMedcomp · 2002
  4. 4 generations backK030020 Hemosplit Long-Term Hemodialysis CatheterC.R. Bard, Inc. · 2003
  5. 3 generations backK033294 Hemosplit XK, Hemosplit XK Catheter, 16FR X 42 CM, Kit;16FR X 19 CM…C.R. Bard, Inc. · 2003
  6. 2 generations backK051748 Hemoglide Series and Hemoglide Star Series XK Long-Term Hemodialysis…C.R. Bard, Inc. · 2005 · Recalled
  7. 1 generation backK190527 GlidePath Long-Term Hemodialysis Catheters, HemoStar Long-Term…C. R. Bard · 2020
  8. This deviceK200627 GlidePath 10F Long-Term Dialysis CatheterC.R. Bard, Inc. · 2020
  9. Descendant · cites it directly · 1 of its ownK202150 GlidePath 7.5F Long-Term Dialysis CatheterC.R. Bard, Inc. · 2020
  10. Descendant · 2 generations on · 0 of its ownK241581 Hemodialysis CatheterHaolang Medical USA Corporation · 2025

Class I recalls in this family

Most influential descendants

Showing 2 of 2 · See all
  • K202150GlidePath 7.5F Long-Term Dialysis CatheterC.R. Bard, Inc. · 2020 · cites it directly1descendant
  • K241581Hemodialysis CatheterHaolang Medical USA Corporation · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K981994Vascath Opti-Flow Long Term Dual Lumen Hemodialysis CatheterC.R. Bard, Inc.1998—
−6K012562Medcomp 14.5F Double Lumen Hemodialysis CatheterMedical Components, Inc.2002—
−5K020465Medcomp Ash Split-Cath IIMedcomp2002—
−4K030020Hemosplit Long-Term Hemodialysis CatheterC.R. Bard, Inc.2003—
−3K033294Hemosplit XK, Hemosplit XK Catheter, 16FR X 42 CM, Kit;16FR X 19 CM, Kit with…C.R. Bard, Inc.2003—
−2K051748Hemoglide Series and Hemoglide Star Series XK Long-Term Hemodialysis CathetersC.R. Bard, Inc.200513
−1K190527GlidePath Long-Term Hemodialysis Catheters, HemoStar Long-Term Hemodialysis…C. R. Bard2020—
0 (this device)K200627GlidePath 10F Long-Term Dialysis CatheterC.R. Bard, Inc.2020—
+1K202150GlidePath 7.5F Long-Term Dialysis CatheterC.R. Bard, Inc.2020—
+2K241581Hemodialysis CatheterHaolang Medical USA Corporation2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
199911
200120
200210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
202510
FIG. 1 — Lineage of K200627, 1998–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MSD device

  1. #1 K241581 Hemodialysis Catheterscore 12.3 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K190527GlidePath Long-Term Hemodialysis Catheters, HemoStar Long-Term Hemodialysis Catheters…
Summary page 4
…lation Number: 21 CFR 876.5540 Classification Panel: Gastroenterology/Urology Predicate Device: Bard GlidePath™ Long-Term Hemodialysis Catheter (K190527, cleared March 5, 2020) Pediatric Reference Device: Medcomp Pediatric Ash Split Cath™ XL 10F (K020936, cleared October 11, 2002…
C. R. Bard2020—
*K02093610F X 18CM Pediatric Ash Split Cath XL, Model ASPC18P-XL; 10F X 24CM Pediatric Ash…
Summary page 4
…edicate Device: Bard GlidePath™ Long-Term Hemodialysis Catheter (K190527, cleared March 5, 2020) Pediatric Reference Device: Medcomp Pediatric Ash Split Cath™ XL 10F (K020936, cleared October 11, 2002)…
Medcomp2002—

Also cleared against K190527: 2 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K202150GlidePath 7.5F Long-Term Dialysis CatheterC.R. Bard, Inc.20201

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K984022Pediatric Two-Lumen Hemodialysis Catherization KitArrow Intl., Inc. · 1999 · 2 generations back · ◆ in the 1999 ancestors bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 22 years and passes through 4 companies; a new generation was cleared every 1.1 years on median.
  • 2 of the 12 ancestors have a recall of any class; 1 has a Class I recall.
  • Of its descendants, K202150 (C.R. Bard, Inc., 2020) has gone furthest, with 1 descendant of its own.
  • 2 other devices also cite its predicate K190527.

How does its category compare?

All MSD devices

MSD Catheter, Hemodialysis, Implanted: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · MSD

1in 2025

2007: 72008: 32009: 62010: 42011: 72012: 22013: 52014: 82015: 12016: 22017: 22018: 22019: 12020: 42021: 42025: 1
2007high 8 (2014) · low 0 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MSD

153in 2021

2007: 92 days median2008: 89 days median2009: 81 days median2010: 116 days median2011: 70 days median2013: 105 days median2014: 246 days median2020: 106 days median2021: 153 days median
2007high 246 (2014) · low 70 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MSD

1in 2013

2008: 472009: 492010: 112011: 242013: 12026 (partial year): 4, 4 Class I
2007high 49 (2009) · low 0 (2007)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · MSD

1,054in 2025

2007: 1182008: 1742009: 1732010: 3062011: 2682012: 3672013: 3632014: 5062015: 5502016: 5322017: 4842018: 4632019: 6452020: 4012021: 5232022: 6102023: 5422024: 8412025: 1,054
2007high 1,054 (2025) · low 118 (2007)2025

MAUDE reports naming product code MSD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20077920118
200838947174
200968149173
2010411611306
201177024268
20122—0367
201351051363
201482460506
20151—0550
20162—0532
20172—0484
20182—0463
20191—0645
202041060401
202141530523
20220—0610
20230—0542
20240—0841
20251—01,054
20260—4 (4)—

What is it indicated for?

The GlidePath™ 10F long-term hemodialysis catheter is indicated for use in attaining short-term or long-term vascular access in pediatric, adolescent and adult patients for hemodialysis, hemoperfusion or apheresis as determined by the prescribing physician. Access is attained via the internal jugular vein, subclavian vein, or femoral vein. Catheters longer than 22 cm are intended for femoral vein insertion, depending on patient anatomy and size.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K200627: GlidePath 10F Long-Term Dialysis Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K200627

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026